Annual Drug Patent Expirations for EYSUVIS
Eysuvis is a drug marketed by Alcon Labs Inc and is included in one NDA. It is available from one supplier. There are thirteen patents protecting this drug.
This drug has eigthy-one patent family members in twelve countries.
The generic ingredient in EYSUVIS is loteprednol etabonate. One supplier is listed for this compound. Additional details are available on the loteprednol etabonate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
